...
首页> 外文期刊>Folia histochemica et cytobiologica >Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays — preliminary study
【24h】

Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays — preliminary study

机译:SATB1蛋白在乳腺导管组织微阵列中的表达—初步研究

获取原文
           

摘要

Abstract: Special AT-rich sequence-binding protein 1 (SATB1) is a nuclear matrix protein which interacts with specific regions of DNA, ensuring its proper organization and function in the cell. The expression of SATB1 was primarily found in thymocytes, but its increased levels were observed in various types of cancers. However, the knowledge of the function and application possibilities of this protein is still limited. The aim of this study was to investigate the expression of SATB1 protein using immunohistochemistry and tissue microarray (TMA) technique and determine its possible relationship with the proliferative marker Ki-67, estrogen a (ER) and progesterone (PR) receptors as well as grade of histological malignancy (G). The study was performed on material of 48 archival invasive ductal breast cancers (IDC). The TMAs were prepared with the use of 0.6 mm diameter punches. Immunohistochemical reactions were carried out using antibodies against Ki-67, ER, PR and SATB1 proteins. The intensity of the nuclear reaction was evaluated using a light microscope and computer-assisted image analysis. Expression of Ki-67 and SATB1 protein was observed in 89.58% and 31.25% of cancer cases, respectively. 62.5% of tumors were classified as ER-positive, and 47.92% as PR-positive. Statistical analysis showed a moderate positive correlation between Ki-67 and SATB1 expression (r = 0.291, p = 0.045 independently on the receptor status, and r = 0.392, p = 0.032 in ER-negative tumors). The expression of the Ki-67 antigen increased with higher grade of histological malignancy (G). The results suggest that SATB1 protein may play an indirect role in the cell proliferation and should be evaluated in relation to the other markers. Further studies concerning determination of its role in cancer progression and metastasis, in terms of application as therapeutic target and prognostic marker, are recommended.
机译:摘要:富含AT的特殊序列结合蛋白1(SATB1)是一种核基质蛋白,可与DNA的特定区域相互作用,从而确保其在细胞中的适当组织和功能。 SATB1的表达主要在胸腺细胞中发现,但在各种类型的癌症中均观察到其水平升高。但是,对该蛋白的功能和应用可能性的认识仍然有限。这项研究的目的是使用免疫组织化学和组织微阵列(TMA)技术研究SATB1蛋白的表达,并确定其与增殖标记Ki-67,雌激素a(ER)和孕激素(PR)受体以及等级的可能关系。组织学恶性(G)。该研究是针对48种档案浸润性导管癌(IDC)的材料进行的。使用0.6毫米直径的冲头制备TMA。使用针对Ki-67,ER,PR和SATB1蛋白的抗体进行免疫组织化学反应。使用光学显微镜和计算机辅助图像分析评估核反应的强度。 Ki-67和SATB1蛋白的表达分别在89.58%和31.25%的癌症病例中观察到。 62.5%的肿瘤被分类为ER阳性,而47.92%的肿瘤被分类为PR阳性。统计分析显示,Ki-67和SATB1表达之间存在中等正相关(r = 0.291,p = 0.045,独立于受体状态,而ER阴性肿瘤中r = 0.392,p = 0.032)。 Ki-67抗原的表达随组织恶性程度(G)的升高而增加。结果表明SATB1蛋白可能在细胞增殖中起间接作用,应该与其他标记物进行评估。建议就其作为治疗靶标和预后标志物的应用进行有关确定其在癌症进展和转移中的作用的进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号